Call: A randomized placebo controlled trial called SCOUT (Sibutramine Cardiovascular Outcomes Trial) was launched in 2002 and enrolled over 10,000 overweight or obese individuals with diabetes or a history of coronary or peripheral vascular disease or stroke, along with other CV risk factors. At the conclusion of the trial, an early analysis for the trial’s primary […]
Tagged : meridia, weight loss medications
Comments : give a response
